Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie Callison

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Antiviral Research|June 12, 2013
A novel Ebola virus expressing luciferase allows for rapid and quantitative testing of antiviralsThomas Hoenen, Allison Groseth, Julie Callison, et al.
The Journal of Infectious Diseases|May 15, 2023
Single-Dose Treatment With Vesicular Stomatitis Virus-Based Ebola Virus Vaccine Expressing Ebola Virus-Specific Artificial Micro-RNA Does Not Protect Mice From Lethal DiseaseKyle L O'Donnell, Julie Callison, Heinz Feldmann, et al.
Scientific Reports|April 19, 2013
Inhibition of novel β coronavirus replication by a combination of interferon-α2b and ribavirinDarryl Falzarano, Emmie de Wit, Cynthia Martellaro, et al.
Journal of Virology|May 20, 2011
Clinical outcome of henipavirus infection in hamsters is determined by the route and dose of infectionBarry Rockx, Douglas Brining, Joshua Kramer, et al.
Scientific Reports|July 25, 2018
A VSV-based Zika virus vaccine protects mice from lethal challengeJackson Emanuel, Julie Callison, Kimberly A Dowd, et al.
The Journal of Infectious Diseases|October 12, 2011
Vesicular stomatitis virus-based Ebola vaccines with improved cross-protective efficacyAndrea Marzi, Hideki Ebihara, Julie Callison, et al.
The Journal of Infectious Diseases|May 11, 2015
Soluble Glycoprotein Is Not Required for Ebola Virus Virulence in Guinea PigsThomas Hoenen, Andrea Marzi, Dana P Scott, et al.
Journal of Virology|June 27, 2014
A novel life cycle modeling system for Ebola virus shows a genome length-dependent role of VP24 in virus infectivityAri Watt, Felicien Moukambi, Logan Banadyga, et al.
The Journal of Infectious Diseases|May 23, 2015
Development and Characterization of Broadly Cross-reactive Monoclonal Antibodies Against All Known Ebolavirus SpeciesHumberto Hernandez, Caleb Marceau, Hailey Halliday, et al.
Emerging Infectious Diseases|May 20, 2021
Ebola Virus IgG Seroprevalence in Southern MaliSidy Bane, Kyle Rosenke, Ousmane Maiga, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Antiviral Research|June 12, 2013
A novel Ebola virus expressing luciferase allows for rapid and quantitative testing of antiviralsThomas Hoenen, Allison Groseth, Julie Callison, et al.
The Journal of Infectious Diseases|May 15, 2023
Single-Dose Treatment With Vesicular Stomatitis Virus-Based Ebola Virus Vaccine Expressing Ebola Virus-Specific Artificial Micro-RNA Does Not Protect Mice From Lethal DiseaseKyle L O'Donnell, Julie Callison, Heinz Feldmann, et al.
Scientific Reports|April 19, 2013
Inhibition of novel β coronavirus replication by a combination of interferon-α2b and ribavirinDarryl Falzarano, Emmie de Wit, Cynthia Martellaro, et al.
Journal of Virology|May 20, 2011
Clinical outcome of henipavirus infection in hamsters is determined by the route and dose of infectionBarry Rockx, Douglas Brining, Joshua Kramer, et al.
Scientific Reports|July 25, 2018
A VSV-based Zika virus vaccine protects mice from lethal challengeJackson Emanuel, Julie Callison, Kimberly A Dowd, et al.
The Journal of Infectious Diseases|October 12, 2011
Vesicular stomatitis virus-based Ebola vaccines with improved cross-protective efficacyAndrea Marzi, Hideki Ebihara, Julie Callison, et al.
The Journal of Infectious Diseases|May 11, 2015
Soluble Glycoprotein Is Not Required for Ebola Virus Virulence in Guinea PigsThomas Hoenen, Andrea Marzi, Dana P Scott, et al.
Journal of Virology|June 27, 2014
A novel life cycle modeling system for Ebola virus shows a genome length-dependent role of VP24 in virus infectivityAri Watt, Felicien Moukambi, Logan Banadyga, et al.
The Journal of Infectious Diseases|May 23, 2015
Development and Characterization of Broadly Cross-reactive Monoclonal Antibodies Against All Known Ebolavirus SpeciesHumberto Hernandez, Caleb Marceau, Hailey Halliday, et al.
Emerging Infectious Diseases|May 20, 2021
Ebola Virus IgG Seroprevalence in Southern MaliSidy Bane, Kyle Rosenke, Ousmane Maiga, et al.
Pageof 3